Assuntos: FÁRMACOS (SISTEMA CARDIOVASCULAR), DOENÇAS CARDIOVASCULARES (TERAPIA), CUSTOS DOS CUIDADOS DE SAÚDE, CUSTOS DE MEDICAMENTOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JANZON, M. et al. Health economic analysis of ticagrelor in patients with acute coronary syndromes intended for non-invasive therapy. Heart, v. 101, n. 2, p. 119-125, 2015Tradução . . Disponível em: https://doi.org/10.1136/heartjnl-2014-305864. Acesso em: 07 nov. 2024.APA
Janzon, M., James, S., Cannon, C. P., Storey, R. F., Mellström, C., Nicolau, J. C., et al. (2015). Health economic analysis of ticagrelor in patients with acute coronary syndromes intended for non-invasive therapy. Heart, 101( 2), 119-125. doi:10.1136/heartjnl-2014-305864NLM
Janzon M, James S, Cannon CP, Storey RF, Mellström C, Nicolau JC, Wallentin L, Henriksson M. Health economic analysis of ticagrelor in patients with acute coronary syndromes intended for non-invasive therapy [Internet]. Heart. 2015 ; 101( 2): 119-125.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1136/heartjnl-2014-305864Vancouver
Janzon M, James S, Cannon CP, Storey RF, Mellström C, Nicolau JC, Wallentin L, Henriksson M. Health economic analysis of ticagrelor in patients with acute coronary syndromes intended for non-invasive therapy [Internet]. Heart. 2015 ; 101( 2): 119-125.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1136/heartjnl-2014-305864
